derekliz Posted February 21, 2013 Report Share Posted February 21, 2013 Found this information on the Dysautonomia International Facebook Page: We received great news today from Chelsea Therapeutics on some progress in the FDA approval process for their drug, Droxidopa, which will hopefully be approved to treat Neurogenic Orthostatic Hypotension (OH) later this year! This would be... a MAJOR breakthrough for patients suffering from OH. See Chelsea's press release here: http://bit.ly/ZhHkdxThis is a critical time in the FDA's review process. If you or a loved on has OH, please act now to share your story with the FDA. The need to here about the need for more options for OH patients. Visit www.treatNOHnow.comFound this information on the Dysautonomia Internation Facebook Page Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.